日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma

小鼠RET+肺腺癌获得性TKI耐药及有效联合治疗策略模型

期刊:
影响因子:
doi:10.1101/2025.06.04.657911
Hinz, Trista K; Le, Anh T; Doan, Tristan; Ast, Abby; Jaramillo, Sophia; Haines, Samantha; Navarro, Andre; Patil, Tejas; Nemenoff, Raphael A; Heasley, Lynn E
肿瘤
肿瘤免疫
RET
发表日期：2025
文献求助 收藏

The dataset of duplex ultrasound assessment of the internal mammary artery in women with unilateral mastectomy followed by radiotherapy for breast cancer

本数据集包含接受单侧乳房切除术后行乳腺癌放疗的女性患者的乳内动脉双功能超声评估结果。

期刊:Data in Brief
影响因子:1.4
doi:10.1016/j.dib.2023.110004
Le, Thanh-Phong; Le, Anh T; Huynh, Tan N D; Dao, Thu-Ha; Desgranges, Pascal; Bosc, Romain
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Evaluation of KRAS(G12C) inhibitor responses in novel murine KRAS(G12C) lung cancer cell line models

在新型小鼠KRAS(G12C)肺癌细胞系模型中评估KRAS(G12C)抑制剂的反应

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1094123
Sisler, Daniel J; Hinz, Trista K; Le, Anh T; Kleczko, Emily K; Nemenoff, Raphael A; Heasley, Lynn E
细胞生物学
肿瘤
肿瘤免疫
肺癌
RAS
发表日期：2023
文献求助 收藏

The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib

克唑替尼治疗IV期ROS1重排非小细胞肺癌脑转移发生率及中枢神经系统进展率

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1016/j.jtho.2018.07.001
Patil, Tejas; Smith, Derek E; Bunn, Paul A; Aisner, Dara L; Le, Anh T; Hancock, Mark; Purcell, William T; Bowles, Daniel W; Camidge, D Ross; Doebele, Robert C
肺癌
肿瘤
肿瘤免疫
神经科学
细胞生物学
发表日期：2018
文献求助 收藏

Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples

对一组阳性患者样本中 ROS1 重排的分子检测方法进行比较

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1016/j.jtho.2018.05.041
Davies, Kurtis D; Le, Anh T; Sheren, Jamie; Nijmeh, Hala; Gowan, Katherine; Jones, Kenneth L; Varella-Garcia, Marileila; Aisner, Dara L; Doebele, Robert C
发表日期：2018
文献求助 收藏

Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non-Small Cell Lung Cancer

无细胞DNA在非小细胞肺癌中ALK融合基因检测及ALK抑制剂耐药基因组机制研究中的临床应用

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-17-2588
McCoach, Caroline E; Blakely, Collin M; Banks, Kimberly C; Levy, Benjamin; Chue, Ben M; Raymond, Victoria M; Le, Anh T; Lee, Christine E; Diaz, Joseph; Waqar, Saiama N; Purcell, William T; Aisner, Dara L; Davies, Kurtis D; Lanman, Richard B; Shaw, Alice T; Doebele, Robert C
肿瘤
ALK
肿瘤免疫
肺癌
细胞生物学
发表日期：2018
文献求助 收藏

Resistance Mechanisms to Targeted Therapies in ROS1(+) and ALK(+) Non-small Cell Lung Cancer.

ROS1(+)和ALK(+)非小细胞肺癌对靶向治疗的耐药机制

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-17-2452
McCoach Caroline E, Le Anh T, Gowan Katherine, Jones Kenneth, Schubert Laura, Doak Andrea, Estrada-Bernal Adriana, Davies Kurtis D, Merrick Daniel T, Bunn Paul A Jr, Purcell W Tom, Dziadziuszko Rafal, Varella-Garcia Marileila, Aisner Dara L, Camidge D Ross, Doebele Robert C
细胞生物学
肺癌
发表日期：2018
文献求助 收藏

TRKing down an old oncogene in a new era of targeted therapy

在靶向治疗的新时代，通过 TRK 抑制旧的癌基因

期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-14-0765
Vaishnavi, Aria; Le, Anh T; Doebele, Robert C
肿瘤
肿瘤免疫
发表日期：2015
文献求助 收藏

The democratization of the oncogene

癌基因的民主化

期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-14-0628
Le, Anh T; Doebele, Robert C
肿瘤
肿瘤免疫
发表日期：2014
文献求助 收藏

Oncogenic fusions involving exon 19 of ALK

涉及ALK基因第19外显子的致癌融合

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1097/JTO.0b013e31826bb94d
Le, Anh T; Varella-Garcia, Marileila; Doebele, Robert C
ALK
肿瘤
肿瘤免疫
发表日期：2012
文献求助 收藏